These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21780654)

  • 1. [Standardization of methotrexate administration in routine rheumatological practice].
    Murav'ev IuV
    Ter Arkh; 2011; 83(5):33-7. PubMed ID: 21780654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should aggressive therapy for rheumatoid arthritis require early use of weekly low-dose methotrexate, as the first disease-modifying anti-rheumatic drug in most patients?
    Pincus T; Sokka T
    Rheumatology (Oxford); 2006 May; 45(5):497-9. PubMed ID: 16537578
    [No Abstract]   [Full Text] [Related]  

  • 3. [Subcutaneous self-administration of methotrexate in rheumatoid arthritis].
    Huisman AM; Schouten JP; van Paassen HC; Wouters JM; Jacobs JW
    Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1564-5. PubMed ID: 8765767
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions.
    Kinder AJ; Hassell AB; Brand J; Brownfield A; Grove M; Shadforth MF
    Rheumatology (Oxford); 2005 Jan; 44(1):61-6. PubMed ID: 15611303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A survey of the doses of methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis].
    Kawai S; Ochi T; Kondo H; Nishioka K; Nobuyuki N; Yoshino S
    Ryumachi; 2002 Feb; 42(1):76-9. PubMed ID: 11925910
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative effectiveness and combined administration of basic drugs in rheumatoid arthritis].
    Noskov SM; Kozlov GS
    Revmatologiia (Mosk); 1991; (1):26-9. PubMed ID: 1676853
    [No Abstract]   [Full Text] [Related]  

  • 7. Limitations of the study of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: comment on the article by Braun et al.
    Raghu P; Grover PS; Kumar A
    Arthritis Rheum; 2008 Jul; 58(7):2209; author reply 2209-10. PubMed ID: 18576338
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine and methotrexate for severe rheumatoid arthritis.
    Malleson P
    N Engl J Med; 1995 Dec; 333(23):1567; author reply 1568-9. PubMed ID: 7477177
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug delivery system of anti-inflammatory and anti-rheumatic drugs].
    Kawai S
    Nihon Rinsho; 1998 Mar; 56(3):782-7. PubMed ID: 9549373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacotherapy of patients with (early) rheumatoid arthritis].
    Jacobs JW; Blaauw AA; Dijkmans BA; van Riel PL; Bijlsma JW
    Ned Tijdschr Geneeskd; 2000 Jan; 144(5):211-6. PubMed ID: 10682647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methotrexate: mainstay of rheumatoid arthritis treatment].
    Jacobs JW; Bijlsma JW
    Ned Tijdschr Geneeskd; 2009; 153():A879. PubMed ID: 19785862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Statement of the German Society of Rheumatology (DGRh) reporting on the Institute's plan for biologicals in the second-line therapy for rheumatoid arthritis].
    Braun J; Krüger K; Genth E
    Z Rheumatol; 2011 Dec; 70(10):882-3. PubMed ID: 22139207
    [No Abstract]   [Full Text] [Related]  

  • 13. Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab.
    Ornetti P; Solau E; Gaudin P; Sibilia J; Berthelot JM; Puechal X; Tavernier C; Maillefert JF;
    Ann Rheum Dis; 2005 Sep; 64(9):1379-80. PubMed ID: 16100349
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
    Schnabel A; Gross WL
    Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of chronic polyarthritis with methotrexate 1994--a review].
    Rau R
    Z Rheumatol; 1994; 53(4):199-229. PubMed ID: 7975933
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis and management of rheumatoid arthritis.
    Kaushik P; Kaushik R
    Am J Med; 2008 Jun; 121(6):e7; author reply e9-10. PubMed ID: 18501219
    [No Abstract]   [Full Text] [Related]  

  • 17. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis.
    Wassenberg S; Rau R
    J Rheumatol; 2003 Aug; 30(8):1891; author reply 1891-2. PubMed ID: 12913889
    [No Abstract]   [Full Text] [Related]  

  • 18. Subcutaneous methotrexate is well tolerated and superior to oral methotrexate in the treatment of rheumatoid arthritis.
    Hameed B; Jones H
    Int J Rheum Dis; 2010 Oct; 13(4):e83-4. PubMed ID: 21199461
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Symmons DP; Watson KD; Silman AJ;
    Arthritis Rheum; 2006 Jun; 54(6):1786-94. PubMed ID: 16736520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging issues in pharmacological management of rheumatoid arthritis: results of a national needs assessment survey identifying practice variations for the development of Canadian Rheumatology Association clinical practice recommendations.
    Bykerk VP; Schieir O; Akhavan P; Hazlewood GS; Cheng CK; Bombardier C
    J Rheumatol; 2012 Aug; 39(8):1555-8. PubMed ID: 21885494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.